IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CATTANEO, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.784
EU - Europa 2.340
AS - Asia 1.441
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 8
AF - Africa 7
OC - Oceania 6
Totale 7.596
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.766
CN - Cina 808
UA - Ucraina 764
DE - Germania 497
IT - Italia 370
SG - Singapore 270
HK - Hong Kong 212
FI - Finlandia 151
RU - Federazione Russa 144
FR - Francia 126
GB - Regno Unito 115
IE - Irlanda 108
TR - Turchia 107
SE - Svezia 21
IN - India 20
CA - Canada 17
BE - Belgio 16
EU - Europa 10
NL - Olanda 7
AU - Australia 6
PL - Polonia 5
BR - Brasile 4
JP - Giappone 4
ID - Indonesia 3
IR - Iran 3
MU - Mauritius 3
AL - Albania 2
AM - Armenia 2
CL - Cile 2
ES - Italia 2
LT - Lituania 2
MA - Marocco 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
HU - Ungheria 1
IQ - Iraq 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
UZ - Uzbekistan 1
VE - Venezuela 1
VN - Vietnam 1
Totale 7.596
Salva come PNG Salva come JPEG
Città #
Jacksonville 532
Fairfield 447
Woodbridge 422
Houston 299
Ann Arbor 239
Hong Kong 212
Princeton 212
Cambridge 209
Singapore 209
Ashburn 203
Wilmington 198
Nanjing 197
Seattle 170
Chandler 143
Beijing 134
Dublin 108
Istanbul 95
New York 78
Nanchang 70
Moscow 58
Hebei 57
Helsinki 52
Des Moines 51
Milan 48
Shenyang 43
Changsha 41
San Diego 35
Kunming 33
Tianjin 32
Jiaxing 31
Lancaster 31
Shanghai 28
Jinan 27
Brussels 16
Hangzhou 15
Nürnberg 15
Verona 15
Toronto 14
Brescia 13
San Francisco 13
Zhengzhou 13
Haikou 12
Rome 12
San Mateo 12
Lanzhou 11
Kocaeli 10
Monmouth Junction 10
Ningbo 10
Augusta 9
Dearborn 9
Los Angeles 9
London 8
Taiyuan 8
Taizhou 8
Trieste 8
Lucera 7
Munich 7
Siena 7
Fuzhou 6
Guangzhou 6
Massa 6
Norwalk 6
Boardman 5
Changchun 5
Genoa 5
Hanover 5
Washington 5
Leawood 4
Radomsko 4
Redwood City 4
Rovato 4
Ardabil 3
Bagnara di Romagna 3
Cagliari 3
Canberra 3
Desenzano del Garda 3
Frankfurt am Main 3
Melbourne 3
Orange 3
Pisa 3
Solarussa 3
Strasbourg 3
Bergamo 2
Breia 2
Chiswick 2
Como 2
Crema 2
Dallas 2
Florence 2
Genova 2
Greenwich 2
Modena 2
Noventa Vicentina 2
Ortona 2
Ottawa 2
Rabat 2
Redmond 2
Reggio Calabria 2
Reggio Nell'emilia 2
Seveso 2
Totale 5.149
Salva come PNG Salva come JPEG
Nome #
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI E LESIONI PUNTIFORMI DELLA SOSTANZA BIANCA ALLA RISONANZA MAGNETICA. QUAL E' IL LORO SIGNIFICATO? VALUTAZIONE DI 169 PAZIENTI CON MANIFESTAZIONI NEUROLOGICHE 164
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 123
In vitro cell death of activated lymphocytes in Omenn's syndrome 116
Desensibilizzazione orale alla rifampicina: descrizione di un nuovo protocollo. 113
Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins 110
CD3-CD4+ cells with a Th2-like pattern of cytokine production in the peripheral blood of a patient with cutaneous T cell lymphoma. 109
Antiphospholipid antibody profile: implications for the evaluation and management of patients. 109
Studio con TC ad alta risoluzione (HRCT) dell’interstizio polmonare in alcune malattie autoimmunitarie sistemiche. 108
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 106
Idiopathic eosinophilic pneumonia and pregnancy: report of a case. 105
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 101
Circulating immune complexes in human acute leukaemia. 99
Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations 98
Inhibitory effect of IgM rheumatoid factor on immune complex solubilization capacity and inhibition of immune precipitation. 97
Antiperinuclear factor in psoriatic arthropathy 95
Expression of CD28 on CD8+ and CD4+ Lymphocytes During HIV Infection 94
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. 93
Upregulation of myxovirus-resistance protein A: a possible marker of type I interferon induction in systemic sclerosis. 93
Immune reconstitution after bone marrow transplantation for combined immunodeficiencies: down modulation of Bcl-2 and high expression of CD95/Fas account for increased susceptibility to spontaneous and activation-induced lymphocyte cell-death 91
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases: a multicentre prospective study. 90
I polimorfismi della metilentetraidrofolatoreduttasi (MTHFR) nel trattamento con methotrexate di pazienti con artrite reumatoide. Revisione della letteratura ed esperienza personale. 90
Nonorgan specific autoantibodies and heart damage. 90
Antiphospholipid antibodies and malignancies 89
IL COMPLEMENTO NELLA GRAVIDANZA DI DONNE AFFETTE DA SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA 89
Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years. 88
Role of anti-prothrombin in antiphospholipid syndrome. 87
Oesophageal manometry in early and definite systemic sclerosis. 85
Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. 84
Anti beta2-glycoprotein I antibodies: clinical significance. 83
Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. 82
Esposizione a latice nelle aziende sanitarie: esperienze pratiche 82
Systemic lupus erythematosus and pregnancy: a prospective study. 81
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. 81
The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/polymyositis 81
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 81
Prevenzione delle reazioni allergiche in pazienti sensibilizzati a latice 80
Vasculite orticarioide: valutazione clinica, laboratoristica e terapeutica di 17 pazienti. 80
Clinical and serological features of 35 patients with anti-Ki autoantibodies. 80
Deforming arthropathy of the hands in Systemic Lupus Erythematosus is associated with antibodies to SS-A/Ro and to SS-B/La. 79
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of Low-dose versus high-dose intravenous cyclophosphamide. 79
RELATIONSHIP BETWEEN SLE SUSCEPTIBILITY GENES AND CLINICAL MANIFESTATIONS IN A COHORT OF PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME 76
The anti-beta-2 glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species' evolution. 75
Antinuclear antibodies in psoriatic arthritis and its subgroups 74
More on anticardiolipin and anti-beta2 glycoprotein I in systemic sclerosis. 74
Chilblain Lupus Erythematosus (CL) è associato ad anticorpi anti SSA/Ro 74
EVALUATION OF NEUROLOGICAL MANIFESTATIONS IN 180 PATIENTS (PTS) WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME (PAPS) 74
Defective expression of HLA class I and CD1a molecules in boy with Marfan-like phenotype and deep skin ulcers 73
Anti-Ro/SSA autoantibodies over time in mothers of children with congenital complete heart block. 72
Pregnancy in systemic sclerosis: a prospective study 70
AUMENTO DELLA PROTEINA C-REATTIVA, ANTICORPI ANTI-CCP E FATTORE REUMATOIDE NELL'ARTRITE LUPICA 70
Proliferazioni di cloni di tipo Th2 con fenotipo CD3- CD4+. Studio di 2 casi. 69
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. 68
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA: FOCUS SULLE MANIFESTAZIONI NEUROLOGICHE 68
Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients 67
Anticorpi antinucleo e artrite psoriasica 67
Esophageal Dysfunction in Patients with Definite and Early Systemic Sclerosis 67
Antiphospholipid and anti beta 2 glycoprotein I antibodies in patients with obstetrical complications 65
Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients. 65
NEUROLOGICAL MANIFESTATIONS IN 169 PATIENTS WITH PAPS: WHICH SIGNIFICANCE FOR SMALL HYPERINTENSE WHITE MATTER LESIONS AT MAGNETIC RESONANCE IMAGING? 64
IL "PROFILO" DEGLI ANTICORPI ANTIFOSFOLIPIDI NELLA SINDROME PRIMARIA COME FATTORE DI RISCHIO PER EVENTI CLINICI: STUDIO DI 175 PAZIENTI 64
IL METHOTREXATE (MTX) E I GENOTIPI DELLA METILENTETRAIDROFOLATOREDUTTASI (MTHFR) NEL TRATTAMENTO DI PAZIENTI ITALIANI CON MALATTIE REUMATICHE 63
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA E LUPUS ERITEMATOSO SISTEMICO: DIFFERENZE E SOMIGLIANZE GENETIHE 63
MANIFESTAZIONI NEUROLOGICHE IN 180 PAZIENTI CON SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA. RUOLO DEI FATTORI DI RISCHIO CARDIOVASCOLARI 63
Chillblain lupus erythematosus is associated with antibodies to SSA/Ro 62
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 62
Anti-Ku antibodies in connective tissue disease: clinical and serologic evaluation of 14 patients. 60
Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune disease. 60
ANTICORPI ANTIFOSFOLIPIDI E NEOPLASIE (aPL E NEOPLASIE) 60
PREGNANCY OUTCOMES IN WOMEN EXPOSED TO BIOLOGIC TREATMENT AND AFFECTED BY CHRONIC ARTHRITIS 60
The neonatal lupus erythematosus associated with isolated LA(SSB) antibodies. 60
Antinuclear antibodies and psoriatic arthritis 59
Antiperinuclear factor (APF) in patients with psoriasic arthtritis 59
Discordance for Systemic LupusErythematosus and Hyper IgE Syndrome in a pair of monozygous twins 58
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 58
Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases 57
ANTICORPI ANTI-SU NELLA SINDROME DA ANTICORPI ANTI-FOSFOLIPIDI PRIMARIA (PAPS) 57
CONNETTIVITE INDIFFERENZIATA (UCTD) DI RECENTE DIAGNOSI: PROFILO CLINICO ED IMMUNOLOGICO 57
Lymphadenopathic and oropharyngeal Kaposi's sarcoma in a drug addict with acquired immunodeficiency syndrome. Immunological abnormalities in peripheral blood and lymphoid tissue 57
Oesophageal dysfunction in patients with definite and early systemic sclerosis 56
Chilblain Lupus Erythematosus (CL) is associated with antibodies SSA/Ro 55
Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients 55
Chronic urticaria induced by eradication therapy of Helicobacter pilori: a case report. 53
Esofagopatia sclerodermia in pazienti con sclerosi sistemica (SSC) “precoce” secondo Le Roy-Mesdger: confronto con altri subset di malattia. Studio clinico-manometrico di 181 pazienti 53
Induction of experimental SLE in naive mice by immunization with human polyclonal anti-DNA antibody carrying the 16/6 idiotype. 53
Decreased number of peripheral blood CD4 + CD29+ lymphocytes and increased in vitro spontaneous production of anti-DNA antibodies in patients with active systemic lupus erythematosus. 53
Undifferentiated connective tissue disease with antibodies to Ro/SSA: clinical features and follow-up of 148 patients 52
Anti-TNFalpha treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies. 51
L'orticaria. 51
Isotype switching and titer variation of anti-Ro/SSA antibodies over time in 100 patients with undifferentiated connective tissue disease (UCTD). 51
Pretransplant antitumor conditioning (fTBI dose) correlates with bone marrow histology at day 0 in leukemic patients. 50
Esophageal manometry in patients with definitive and early systemic sclerosis 50
Lessons from the "Euro-Lupus Cohort". 50
LA RIDUZIONE DEL NUMERO ASSOLUTO DELLE CELLULE T CD8+CD28- CIRCOLANTI ENTRO 6 MESI DI TERAPIA CON ABATACEPT COME FATTORE PREDDITIVO DI BUONA RISPOSTA CLINICA A 1 ANNO 49
[A high-resolution computed tomographic study of the pulmonary interstitium in systemic autoimmune diseases] Studio con tomografia computerizzata con alta risoluzione dell’interstizio polmonare in alcune malattie autoimmunitarie sistemiche. 48
TERAPIE BIOLOGICHE E GRAVIDANZA: RISULTATI DI UNO STUDIO MULTICENTRICO ITALIANO 48
Lupus neonatale: manifestazioni cliniche e rischio di blocco cardiaco congenito in neonati da madri con anticorpi anti-Ro/SSA. 47
Antiphospholipid antibodies and intestinal pathology 47
Anti-Ro/SSA antibodies in rheumatoid arthritis: clinical and immunologic associations. 46
Evaluation of suppressor activity in systemic lupus erythematosus. 43
Anti-TNFalpha agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients 42
Totale 7.359
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.268
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.155 0 0 0 0 0 182 117 206 100 323 94 133
2020/20211.197 17 149 21 139 36 138 45 153 236 78 166 19
2021/2022763 29 152 14 56 12 27 22 56 39 87 70 199
2022/2023576 113 5 5 20 58 173 3 54 96 3 16 30
2023/2024630 53 19 41 31 13 102 21 23 216 3 1 107
2024/2025523 2 7 5 177 218 114 0 0 0 0 0 0
Totale 7.662